Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +15.1%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 51–100 of 692 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07819604	Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer	not yet recruiting	Phase 2	85	Xijing HospitalOTHER	0	Sep 15, 2026	clinicaltrials
NCT03074513	Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors	active not recruiting	Phase 2	133	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials